Private Profits versus Public Policy: The Pharmaceutical Industry and the Canadian State
- ISBN-10
- 1442626593
- ISBN-13
- 9781442626591
- Category
- Drug development
- Pages
- 384
- Language
- English
- Published
- 2016
- Publisher
- University of Toronto Press
- Author
- Joel Lexchin
Description
In his new work, Private Profits versus Public Policy, Joel Lexchin addresses this question as he examines how public policy with respect to the pharmaceutical industry has evolved in Canada over the past half century.
Get the book
Other editions
-
- 2016-10-27
- 384 pages
- Ebook
- University of Toronto Press
Similar books
-
Systems Thinking in Medicine and New Drug Discovery
By Robert E. SmithThis book will appeal to specialists, who will find recommendations on safer materials for 3D bioprinting and ways to analyze dietary supplements for toxic contaminants, and physicians, pharmacists and non-professionals, who will learn the ...
-
Synthetic Methods in Drug Discovery: Volume 1
By David C. Blakemore, Paul M. Doyle, Yvette M. FobianWhat are the current industrial research problems and how can they be resolved in an industrial setting? This book highlights key methods that have real impact in drug discovery and facilitate delivery of drug molecules.
-
The Pathway to Operational Excellence in the Pharmaceutical Industry: Overcoming the Internal Inertia
By Thomas FriedliDas beeinträchtigte Innovationen im Produkt- und Substanzbereich. Veränderungen werden an Geschwindigkeit und Umfang zunehmen. Hier setzt die Operational Excellence ein.
-
Complete Accounts of Integrated Drug Discovery and Development: Recent Examples from the Pharmaceutical Industry
By Jaan A. Pesti, Ahmed F. Abdel-Magid, Rajappa VaidyanathanThe chapters in this book are written to accentuate the interdependency and synergy between drug discovery and process development disciplines to advance a new chemical entity into clinical trials and eventually to the market.
-
Design and Delivery of SiRNA Therapeutics
By Henrik J. Ditzel, Martina Tuttolomondo, Sakari KauppinenThis volume details protocols on rationale design of therapeutic siRNA molecules and its encapsulation with smart vehicles to overcome the barriers to an effective administration in vivo.
-
Drug Target Selection and Validation
By Marcus T. Scotti, Carolina L. BelleraConcepts and case studies in chemical biology. John Wiley & Sons, Inc.; 2014. Pai MY, et al. Drug affinity responsive target stability (DARTS) for small-molecule target identification. Methods Mol Biol. 2015;1263:287–98. Rock FL, et al.
-
Burger's Medicinal Chemistry, Drug Discovery and Development
By Donald J. AbrahamBringing in a new and expert editorial board, this new edition updates existing chapters and adds 35 new ones, with topics including: opioid addiction treatments, antibody and gene therapy for cancer, blood-brain barrier, HIV treatments, ...
-
Pharmacological Research on Traditional Herbal Medicines
By WantanabeIntroducing many pharmacological advances made, the work also describes the modern theories and scientific methodologies applied to today's studies on herbal medicines and new drug development.
-
Pharmaceutical Innovation: Revolutionizing Human Health
By Basil Achilladelis, Ralph Landau, Alexander ScriabineDocuments how science has provided an astonishing array of medicines for coping with human ailments. This volume addresses industry leaders, economic influences, and the development of individual products.
-
Capitalizing a Cure: How Finance Controls the Price and Value of Medicines
By Victor Roy... drug development. Soothing the “ups and downs” of finance that Gilead's founder, Riordan, had warned his employees about many years ago required a balm of its own sort, one not discovered in its laboratories but driven by Wall Street ...